Eiger BioPharmaceuticals' hepatitis delta campaign has been launched across the country. Read More »

Sunovion Pharmaceuticals' acquisition of Cynapsus Therapeutics has been finalized through Sunovion's subsidiary Sunovion CNS Development Canada. Read More »

CymaBay Therapeutics will present results of its Phase 2 proof-of-concept MBX-8025 clinical trial at the Annual Meeting of the American Association for the Study of Liver Diseases Nov. 11-15 in Boston. Read More »

Arrow Pharmaceuticals intends to give two presentations at The Liver Meeting 2016 on its investigational medicine designed to treat liver disease linked to alpha-1 antitrypsin deficiency, ARC-AAT. Read More »

CVS Health has launched CVS Pay across the country. Read More »